KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Cheng Chi
Head of China & HK, Global Transfer Pricing Services
+86 (21) 2212 3433
+86 (21) 2212 2888
Cheng Chi Partner - Head of China & HK
Amy Rao Director
+86 (10) 8508 5000
Irene Yan Partner
Tiansheng Zhang Director
Leonard Zhang Partner
+86 (755) 2574 1000
Eileen Sun Partner
Michelle SunDirector
Hong Kong SAR
+852 2522 6022
Kari Pahlman Principal - Asia Pacific Leader
Kari Pahlman
Asia Pacific Leader, Global Transfer Pricing Services
+852 2143 8777
Yasuhiko Otani Partner
Hoyin Leung Director
Tony Feng Director
David Chamberlain Director
Kelly Liao Partner
Karmen Yeung Partner
John Kondos Asia Pacific Leader, Financial Services - Transfer Pricing
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Submit an enquiry about our services, industry practices, or get in touch with one of our professionals.